UK Court Invalidates AstraZeneca's Seroquel XR Patent
The U.K.'s High Court of Justice has invalidated an AstraZeneca AB patent for the extended release version of the company's anti-psychotic drug Seroquel XR, the drugmaker said Thursday....To view the full article, register now.
Already a subscriber? Click here to view full article